FY $12/31$RovenueCost of Goods SoldGross ProfitSales and Marketing $($S&M$)$General and AdminResearch and DevelopmentDepreciation and AmortizationTotal Operating CostsOperating Income$|$Interesi IncomeInterest ExpensePre Tax IncomeTax $(21\%)$Net IncomeEPS $-$ BasicEPS$-$ DilutedShares OutstandingShares Outstanding for Diluled$2023130,000,00071,500,000100\mathrm{.}0\%58,500,00045\mathrm{.}0\%26,000,00014,300,0005,000,000350,000715,000$INCOME STATEMENTCommonSize$4,375\mathrm{.}35016,459,6501\mathrm{.}505,000,00050,300,00038\mathrm{.}7\%11\mathrm{.}000,00055\mathrm{.}0\%20\mathrm{.}0\%21,200,00016\mathrm{.}3\%11\mathrm{.}0\%3\mathrm{.}8\%3\mathrm{.}8\%0\mathrm{.}3\%20,835,00016\mathrm{.}0\%0\mathrm{.}6\%0\mathrm{.}0\%34\%12\mathrm{.}7\%$AssumpionsRevenue $15\%$G$.$ Margins $0\mathrm{.}5\%$S&M $1\mathrm{.}0\%($CSB$)$G&A improves $1\mathrm{.}0\%($CSB$)$R&D S$500,000($S value$)$D&A Stable $($S value$)$Approx $5\mathrm{.}4\%$ of Avg. Cash$8\mathrm{.}5\%$ of Total Installment Debt Obligations$21\%5$ mil common stock warrants exercisable @ S$4\mathrm{.}60.$ Stock price for calculations $=$$$5\mathrm{.}002024$E$149\mathrm{.}500,0001,000\mathrm{.}00011\mathrm{.}000,000149,500,0001\mathrm{.}000\mathrm{.}00011\mathrm{.}000\mathrm{.}000$